Skip to main content
. 2019 Aug 14;17:266. doi: 10.1186/s12967-019-2012-2

Fig. 1.

Fig. 1

Melanoma-specific survival following completion lymph-node dissection or observation in the per-protocol analysis of the trial by Faries et al. [4]. Reproduced with permission